Jim Simons Singular Genomics Systems, Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.4 - $0.61 $16,100 - $24,552	-40,250 Reduced 26.58%	111,200 $57,000
Q4 2023 Feb 13, 2024	SELL	$0.33 - $0.58 $716 - $1,258	-2,170 Reduced 1.41%	151,450 $70,000
Q3 2023 Nov 14, 2023	BUY	$0.37 - $0.99 $16,250 - $43,480	43,920 Added 40.04%	153,620 $59,000
Q2 2023 Aug 11, 2023	BUY	$0.78 - $1.28 $68,016 - $111,616	87,200 Added 387.56%	109,700 $91,000
Q1 2023 May 12, 2023	BUY	$1.1 - $2.95 $3,300 - $8,850	3,000 Added 15.38%	22,500 $27,000
Q4 2022 Feb 13, 2023	SELL	$1.82 - $2.71 $30,394 - $45,257	-16,700 Reduced 46.13%	19,500 $39,000
Q3 2022 Nov 14, 2022	SELL	$2.5 - $4.73 $38,750 - $73,315	-15,500 Reduced 29.98%	36,200 $91,000
Q2 2022 Aug 12, 2022	SELL	$2.86 - $6.44 $125,013 - $281,498	-43,711 Reduced 45.81%	51,700 $197,000
Q1 2022 May 13, 2022	BUY	$5.94 - $12.09 $566,741 - $1.15 Million	95,411 New	95,411 $602,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.54B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.